Lyme Disease Treatment with Stem Cells
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Combat Lyme disease naturally. Advanced regenerative medicine approach to slow or stop disease progression with 95% success in preventing advancement.
Evidence at a glance — Post-treatment Lyme disease symptoms
A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.
- Human studies available?
- None identified
- Randomised trials?
- None identified
- Main outcomes studied
- Symptom scores
- Fatigue
- Function
- Long-term evidence
- Very limited
- Regulatory approval for this indication
- United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
- European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
- United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
- Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
- Role at our centre
- Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it
What kind of evidence exists
- Mechanism (laboratory): Documented
- Animal / preclinical: Documented
- Early human (phase 1/2, uncontrolled): Not established
- Controlled human (randomised or sham-controlled): Not established
- Regulatory approval: Not established
Sources
- Systematic reviews and meta-analyses — Post-treatment Lyme disease symptoms — PubMed
- Randomised controlled trials — Post-treatment Lyme disease symptoms — PubMed
- Registered MSC trials — Post-treatment Lyme disease symptoms — ClinicalTrials.gov
- FDA — Consumer alert on regenerative medicine therapies — U.S. Food and Drug Administration, 2024
- Advanced therapy medicinal products: overview — European Medicines Agency, 2025
- ISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research, 2021
- ISSCR Patient Handbook on Stem Cell Therapies — International Society for Stem Cell Research, 2020
Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.
This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.
What is Lyme Disease?
Lyme disease, also known as Borreliosis, is a bacterial infection caused by Borrelia burgdorferi that is primarily transmitted through tick bites. It can affect multiple organ systems including the skin, central nervous system, eyes, heart, and joints.
While antibiotics can treat the initial infection, symptoms may persist for months or even years in some patients. This condition, known as Post-Treatment Lyme Disease Syndrome, includes muscle pain, joint stiffness, neurological problems, and chronic fatigue.
Regenerative medicine approach offers a revolutionary approach by transforming into cells of injured organs when they come into contact with them. This can halt disease progression, stop it completely, or even cause regression of symptoms.
Recognizing Lyme Disease Symptoms
Symptoms can vary widely and may appear weeks, months, or years after infection.
Early Symptoms
Fatigue, tremor, fever, headache, muscle and joint pain, lymph node swelling within 3-30 days of tick bite.
Bull's-Eye Rash
Erythema migrans (EM) - a characteristic red rash with expanding ring appearance affecting 70% of infected people.
Neurological Issues
Severe headache, stiff neck, facial paralysis, brain inflammation if left untreated.
Chronic Symptoms
Joint inflammation, muscle pain, sleep disturbances, fatigue lasting months or years in 10-20% of patients.
How Our Lyme Disease Treatment Works
A comprehensive regenerative medicine application program designed to combat Lyme disease and its complications.
Comprehensive Assessment
Complete evaluation including physical examination, symptom analysis, and Lyme disease testing.
Care Planning
Personalized protocol based on disease duration, stage, and your overall condition.
Stem Cell Preparation
Mesenchymal stem cells harvested from your adipose tissue or bone marrow, or fetal stem cells.
Laboratory Processing
Cells replicated in Ministry of Health approved laboratories for optimal therapeutic effect.
Administration
Stem cells delivered via vascular access or direct injection to affected tissues/organs.
Follow-up Monitoring
Regular assessment to track improvement and determine if repeat treatments are needed.
Benefits of Regenerative Approach for Lyme Disease
Immune System Support
Stem cells soothe the immune system while enhancing the body's natural defense mechanisms.
Muscle & Joint Relief
Treatment addresses muscle and joint-based symptoms caused by Lyme disease.
95% Success Rate
Therapy greatly reduced progression to advanced stages in 95% of patients treated.
Early Detection Advantage
Early diagnosis dramatically enhances therapy success rate and treatment outcomes.
How Stem Cells Work for Chronic Lyme Disease
Regenerative medicine approach for chronic Lyme disease targets the persistent immune dysfunction and neurological damage that characterize post-treatment Lyme disease syndrome. Mesenchymal stem cells (MSCs) address the complex interplay of chronic inflammation, autoimmune dysregulation, and tissue damage affecting multiple organ systems.
MSCs modulate the dysregulated immune response characteristic of chronic Lyme disease by suppressing overactive inflammatory pathways and promoting immune tolerance. Clinical studies suggest this helps break the cycle of chronic inflammation that perpetuates symptoms long after antibiotic treatment.
Stem cells secrete neurotrophic factors including brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) that support neurological repair. Research indicates these factors can help restore damaged neural pathways responsible for cognitive dysfunction, neuropathy, and brain fog.
MSCs release anti-inflammatory exosomes that cross the blood-brain barrier and reduce neuroinflammation. Clinical observations suggest this mechanism helps address the central nervous system inflammation that drives many chronic Lyme neurological symptoms.
Stem cells promote tissue repair in joints, muscles, and connective tissue damaged by Lyme-related inflammation. Their regenerative signaling helps restore function in musculoskeletal structures affected by chronic Lyme arthritis and myalgia.
Who Is a Good Candidate?
Regenerative medicine approach for chronic Lyme disease is designed for patients experiencing persistent symptoms despite completed antibiotic treatment who seek regenerative support for their ongoing recovery.
Ideal Candidates
- Patients diagnosed with post-treatment Lyme disease syndrome (PTLDS) experiencing persistent fatigue, pain, and cognitive difficulties
- Individuals with chronic Lyme-related neuropathy, brain fog, or other neurological symptoms that have not resolved with standard treatment
- Patients with Lyme-related joint pain, arthritis, or musculoskeletal symptoms persisting beyond antibiotic therapy
- Those with documented history of Lyme disease who experience chronic immune dysregulation and recurring inflammatory symptoms
- Patients who have completed appropriate antibiotic protocols but continue to experience significantly impaired quality of life
May Not Be Suitable
- Patients with active, untreated Borrelia infection requiring primary antibiotic therapy before regenerative treatment
- Individuals with active co-infections (Babesia, Bartonella, Ehrlichia) that have not been adequately addressed
- Patients with severe immunodeficiency conditions that may impair stem cell therapeutic response
- Those with undiagnosed symptoms that have not been properly evaluated to confirm Lyme disease etiology
What Results Can You Expect?
Recovery from chronic Lyme disease with the regenerative approach is a multifaceted process affecting immune, neurological, and musculoskeletal systems. Individual response varies based on symptom duration and severity.
Initial Recovery
Some patients may experience a temporary increase in symptoms (Herxheimer-like reaction) as the immune system recalibrates. Rest and supportive care are recommended during this adjustment period.
Early Improvements
Clinical studies suggest gradual reduction in fatigue levels and joint pain. Sleep quality and overall energy often begin improving as systemic inflammation decreases.
Progressive Results
Cognitive function improvements including reduced brain fog and better concentration are commonly reported. Neuropathic symptoms such as tingling and numbness typically begin to diminish.
Optimal Results
Significant improvements in overall function and quality of life are typically achieved. Many patients report substantially reduced pain levels and restored ability to perform daily activities.
Long-Term Benefits
Continued neurological and immune system recovery with sustained symptom improvement. Many patients experience lasting restoration of cognitive clarity and physical endurance.
Individual results vary. These timelines are based on clinical observations and are not guaranteed outcomes. Your specialist will provide personalized expectations during your consultation.
Patient Experiences
Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul
"My rheumatologist was surprised by the improvement. I can hold my grandchildren's hands again without wincing — that means everything to me."
"Lupus controlled my life for a decade. After treatment in Istanbul, I travelled to three countries in one month — something unimaginable a year ago."
Frequently Asked Questions
Watch Our Patient Stories & Expert Insights
See real results and hear from our medical team about stem cell therapy treatments, procedures, and patient outcomes.
All Regenerative Medicine Applications
Explore our comprehensive range of regenerative medicine applications for various conditions. Click any option to learn more.
Related Articles
Explore our in-depth research articles and guides on related treatments and therapies.
Regenerative Approaches for Autoimmune Conditions: Research & Outcomes
Research on how mesenchymal stem cell approaches modulate the immune system to address autoimmune conditions including lupus, rheumatoid arthritis, and Crohn's disease.
Read ArticleUnderstanding Regenerative Medicine: A Complete Guide
A comprehensive overview of stem cell therapy, including types of stem cells, care processes, safety considerations, and what patients can expect during their wellness journey.
Read ArticleExosome Therapy: The Next Frontier in Regenerative Medicine
Learn about exosome therapy and how these powerful cellular messengers are being studied to support tissue repair, reduce inflammation, and support overall wellness processes.
Read ArticleHow Much Does This Cost Worldwide?
Compare this regenerative medicine costs at StemCell Longevita versus clinics in other countries.
| Country | Typical Cost |
|---|---|
| United States | $20,000 – $35,000 |
| United Kingdom | £15,000 – £28,000 |
| Germany | €18,000 – €32,000 |
| South Korea | $15,000 – $25,000 |
| StemCell Longevita (Turkey) | From £7,600 |
Prices based on market research of comparable stem cell clinics offering umbilical cord-derived MSC treatments (2025-2026). Actual prices vary by clinic, cell count, and condition.
Related clinical questions
Where this page sits in the wider picture.